Discontinued — last reported Q4 '22

Business Segments · Acquisitions

Health & Biosciences — Acquisitions

International Flavors & Fragrances Health & Biosciences — Acquisitions remained flat by 0.0% to $11.25M in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 81.6%, from $61.00M to $11.25M.

Analysis

StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2022Feb 28, 2024

How to read this metric

Higher spending indicates an aggressive growth strategy, while lower spending suggests a focus on organic growth or capital preservation.

Detailed definition

This metric quantifies the capital deployed for the purchase of businesses or assets to expand the Health & Biosciences...

Peer comparison

Widely used across all sectors to track inorganic growth and capital allocation efficiency.

Metric ID: iff_segment_health_biosciences_acquisitions

Historical Data

6 periods
 Q2 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22
Value$403.00M$61.00M$11.25M$11.25M$11.25M$11.25M
QoQ Change-84.9%-81.6%+0.0%+0.0%+0.0%
YoY Change-97.2%-81.6%
Range$11.25M$403.00M
CAGR-94.3%
Avg YoY Growth-89.4%
Median YoY Growth-89.4%
Current Streak3 quarters growth

Frequently Asked Questions

What is International Flavors & Fragrances's health & biosciences — acquisitions?
International Flavors & Fragrances (IFF) reported health & biosciences — acquisitions of $11.25M in Q4 2022.
How has International Flavors & Fragrances's health & biosciences — acquisitions changed year-over-year?
International Flavors & Fragrances's health & biosciences — acquisitions decreased by 81.6% year-over-year, from $61.00M to $11.25M.
What does health & biosciences — acquisitions mean?
The total cash or consideration spent to acquire new businesses within this segment.